secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenon Pharmaceuticals Inc. (XENE)
CIK:        0001582313
Form:       8-K
Filed at:   2025-03-05T23:59:59+00:00
Accession:  0000950170-25-033653
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xenon Pharmaceuticals dismisses KPMG, appoints PwC as independent auditor
-------------------------------------------------------------------------

- Audit Committee dismissed KPMG as independent registered public accounting firm on March 3, 2025.
- No disagreements or reportable events with KPMG during 2024, 2023, or interim period through March 3, 2025.
- Audit Committee approved engagement of PricewaterhouseCoopers LLP for fiscal year ending Dec 31, 2025.
- No prior consultations with PwC regarding accounting principles or audit scope during the two most recent fiscal years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582313/000095017025033653/0000950170-25-033653-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582313/000095017025033653/xene-20250303.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-033653

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer